A real-world study of pertuzumab + trastuzumab in patients with HER2+ metastatic breast cancer in the United States
Latest Information Update: 15 Jul 2021
At a glance
- Drugs Pertuzumab (Primary) ; Trastuzumab-deruxtecan (Primary)
- Indications Advanced breast cancer
- Focus Therapeutic Use
- 15 Jul 2021 New trial record
- 08 Jun 2021 Results presented at the 57th Annual Meeting of the American Society of Clinical Oncology.